D&D Pharmatech

347850 · KOSDAQ · South Korea

Public Market Listing

347850KOSDAQ

KOSDAQ primary exchange listing

Live quotes, historical charts, and market capitalization for D&D Pharmatech are available on Yahoo Finance.

View quote & market cap on Yahoo Finance ↗

External market data link · No third-party exchange redistribution

Assets

(1 total)
1Total Assets
0Approved
0Phase 3 / Filed
1Phase 1–2 / Early
2Diseases
Quick filter:
Showing 1 of 1 assets
Target & Modality
Phase 2
GLP-1/glucagon receptor (dual)Peptide
ObesityMASH / NASH

Upcoming events

No upcoming trial completions or earnings dates on record for this company's assets.

Regulatory and conference events

(1)

Filings, regulator decisions, scientific presentations, topline results and licensing deals, each from a dated source. When a source gives only the month, the month is shown.

Recent

27 May 2026Topline resultDD01DD01 (zabopegdutide) Phase 2 48-week biopsy results positive in MASH
D&D Pharmatech · Source ↗

Financial reports

No financial reports recorded.